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A B S T R A C T
Poly(ADP-ribosyl)ation (PAR) is a post-translational protein modification catalysed by enzyme member of the
poly(ADP-ribose) polymerases (PARPs) family. The activation of several PARPs is triggered by DNA strand
breakage and the main PARP enzyme involved in this process is PARP1. Besides its involvement in DNA repair,
PARP1 is involved in several cellular processes including transcription, epigenetics, chromatin re-modelling as
well as in the maintenance of genomic stability. Moreover, several studies in human and animal models showed
PARP1 activation in various inflammatory disorders. The aims of the study were (1) to characterize PARP1
expression in bovine peripheral blood mononuclear cells (PBMC) and (2) to evaluate PAR levels as a potential
inflammatory marker in cells isolated from blood and milk samples following different types of infection, in-
cluding mastitis. Our results show that (i) bovine PBMC express PARP1; (ii) lymphocytes exhibit higher ex-
pression of PARP1 than monocytes; (iii) PARP1 and PAR levels were higher in circulating PBMCs of infected
cows; (iv) PAR levels were higher in cells isolated from milk with higher Somatic Cell Counts (SCC > 100,000
cells/mL) than in cells from milk with low SCCs. In conclusion, these findings suggest that PARP1 is activated
during mastitis, which may prove to be a useful biomarker of mastitis.
1. Introduction
Poly(ADP-ribosyl)ation is a post-translational modification of cel-
lular proteins highly induced after DNA damage. The reaction is cata-
lysed by poly(ADP-ribose) polymerases (PARPs) (EC 2.4.2.30), an en-
zyme family using NAD+ as substrate to form polymers of ADP-ribose
(PAR). Poly(ADP-ribose) polymerase1 (PARP1) is the best studied fa-
mily member which is responsible for approximately 90% of cellular
PAR formation after genotoxic stress (Bürkle et al., 2004). PARP1 is a
116 kDa nuclear protein that is well conserved during evolution
(Uchida and Miwa, 1994) with a 95% overall amino acid sequence si-
milarity among mammalian species (Beneke et al., 1997). Bovine
PARP1 shares 98% similarity with the human enzyme and the major
caspase cleavage sites are conserved (Saito et al., 1980). Besides DNA
repair, transient PAR formation has also been involved in several other
cellular processes including control of epigenetic profile (Reale et al.,
2005), transcription, chromatin re-modelling (Posavec Marjanovic
et al., 2017; Sultanov et al., 2017), maintenance of genomic stability
(Bai, 2015) and apoptosis (Valenzuela et al. 2002). In cases of in-
flammation resulting in extensive tissue damage, PARP1-mediated PAR
synthesis may be excessive and lead to the cellular depletion of its
substrate NAD+ (Berger, 1985) as well as to cell death signaling
(D’Amours et al., 2001). Several types of cellular stress, including
genotoxic (DNA damaging) agents such as peroxynitrite formed in in-
flammatory processes from nitric oxide (NO), trigger a programmed cell
death pathway, called apoptosis (Brüne, 2005). Apoptosis involves the
activation of caspases to cleave proteins during programmed cell death.
PARP1 cleavage by Caspase-3 has been regarded as a reliable marker of
apoptosis in cellular research for many years (Lazebnik et al., 1994). In
this study we have focused on changes in PARP1 activity associated
with inflammatory responses of the bovine udder.
Mastitis, the inflammation of mammary gland, is a serious disease
that causes huge economic losses to the dairy industry (Rollin et al.,
2015) and has become one of the main research topic in the field of
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dairy science due to the financial losses generated and food safety
concerns over antimicrobial use. Mastitis usually occurs as an immune
response to bacterial invasion of the teat canal by a variety of bacterial
sources present on farms. Following pathogen invasion, the resident
leukocytes together with epithelial cells initiate the inflammatory re-
sponse required to eliminate the invading bacteria (Paape et al., 2003;
Rainard and Riollet, 2006). These cells release chemoattractants for the
rapid recruitment of polymorphonuclear leukocytes (PMN) to the site of
infection. The PMN eliminate pathogens by phagocytosis during which
reactive oxygen species are generated (Paape et al., 2003).
Our study investigated whether the immune cells, involved in pro-
tecting the mammary glands from infection, exhibited increased PARP1
activity. Moreover, we evaluated whether PAR levels increased in cells
isolated from milk particularly during an udder inflammation in dairy
cattle. A few recent studies have reported data on PARP1 in cattle
(Demeyere et al., 2013; Saccà et al., 2016) yet to our knowledge this is
the first study evaluating PARP1 expression and its activity in cells
purified from the blood and milk of dairy cattle. The aims of the study
were (1) to characterize PARP1 expression in bovine peripheral blood
mononuclear cells (PBMC) and (2) to evaluate PAR levels as a potential
marker of inflammation in cells isolated from blood and milk samples
following different types of infection, including mastitis.
2. Materials and methods
2.1. Animals and sample collection
The management and care of the experimental animals was carried
out in compliance with the 86/609EEC European Union directive
guidelines. The animals were kept at the Research Centre for Animal
Production and Aquaculture of CREA where blood samples from lac-
tating cows were collected according to good veterinary practice. Two
separate trials were performed to determine PARP1 and PAR levels in
cells from blood and from milk samples. In the Trial 1, blood samples
were taken from healthy cows in order to evaluate PARP1mRNA (n= 5
cows) and PARP1 protein (n=2 cows) in purified PBMC, lymphocytes
and monocytes. In addition, blood samples from 2 Staphylococcus aureus
were taken from naturally infected cows in order to determine PARP1
and PAR levels in PBMCs isolated during infection. The status of S.
aureus infection was established by the local Institute for animal public
health (Istituto Zooprofilattico Sperimentale-IZSLT). In Trial 2, 36
single quarter milk samples were collected separately from 9 cows in
order to determine PAR levels in purified milk somatic cells. The milk
cells obtained from different udder quarters were separated using the
Somatic Cell Count (SCC), a parameter used as indicator of udder health
and milk quality, considering a threshold of 100,000 cells/mL to define
a quarter as normal (Schwarz et al. 2011; Pilla et al., 2013).
2.2. Trial 1
2.2.1. Isolation of PBMC and separation of lymphocytes and monocytes
The blood samples (50mL) were taken from the external jugular
vein and placed in vacutainer tubes containing anticoagulant EDTA and
PBMC were isolated by density gradient (Lymphoprep™-1.077 g/mL;
AXIS-SHIELD) according to the manufacturer’s instructions. Monocytes
and lymphocytes were separated from purified bovine PBMC (4× 107
cells) by positive selection of monocytes using magnetic CD14
MicroBeads (Miltenyi Biotech) according to the manufacturer's in-
structions and subsequently stored at −80 °C. Furthermore, after se-
paration aliquots of cells were stained with the mouse anti-human
CD14 (clone TÜK4, Miltenyi Biotech), fluorescein isothiocyanate (FITC)
conjugated antibody, and analyzed using a CytoFLEX flow cytometer
(Beckman Coulter Inc). Lymphocytes and monocytes were identified in
a back-gate on FSC versus SSC dot plot and CD14-negative and CD14-
positive cells respectively. Monocytes purity was approximately 98%
and lymphocytes purity was 95%.
2.2.2. Whole cell extract preparation and Western blot analysis
Aliquots of PBMC, lymphocytes and monocytes were thawed on ice
and lysed immediately in RIPA buffer (50mM Tris−HCl at pH 7.4,
150mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS and
1mM EDTA), supplemented with sodium-orthovanadate (3 mM), NaF
(100mM) and a mix of protease inhibitors (Sigma-Aldrich). The lysates
were kept on ice for 25min and then centrifuged (16,000g for 30min at
4 °C). The supernatants were collected and quantified by the Bradford
protein assay reagent (Bio-Rad). The proteins were loaded and sepa-
rated by SDS-PAGE and electro-blotted onto nitrocellulose membrane
(Hybond™ECL™, GE Healthcare). The immunoblots were probed with a
specific PARP1 antibody (clone C2-10, Enzo Life Sciences), which re-
cognizes full length PARP1 (116 kDa) and apoptosis-induced 89 kDa
cleavage fragments, and by a specific anti-PAR antibody (clone 10H
Enzo Life Sciences).
Secondary antibodies, labelled with horseradish peroxidase (HRP),
were used to develop the immunoblot detection using an enhanced
chemoluminescence reaction (ECL Plus, BioRad). Protein levels of the
full length PARP1 band (116 kDa) were quantified densitometrically
using Quantity One Software (Bio-Rad).
In order to control the specificity of anti-PAR antibody, time- de-
pendent PAR formation was assessed in Human colon carcinoma
HCT116 cells treated with the DNA damaging agent doxorubicin (Doxo)
(Sigma-Aldrich). HCT116 cells were grown in high glucose (4.5 g/l)
Dulbecco's modified Eagle's medium supplemented with 10% fetal bo-
vine serum. When the cells were approximately 70% confluent, they
were treated with 1 μM Doxo at different times up to 2 h and when
indicated with ABT-888 (Sigma-Aldrich). More specifically, HCT116
cells were pre-treated with 0,5 μM ABT-888 30min prior to Doxo
treatment and the inhibitor was maintained in the medium throughout
the course of the damage (2 h).
Total cell extracts were obtained by lysis in RIPA buffer, as pre-
viously described. Equal amounts of protein were separated by SDS-
PAGE, electroblotted onto nitrocellulose membrane and probed with
the specific anti-PAR antibody.
2.2.3. Primer design, RNA extraction and RT-qPCR
In order to detect PARP1 gene expression, primers were designed
based on the Bos taurus sequence (Gen Bank Accession Number: NM_
174751) to amplify a 158 bp segment spanning from exon 12 to exon 13
of the bovine PARP1 gene. The ATP synthase, H+ transporting, mi-
tochondrial F1 complex, beta polypeptide (ATP5B) and the mitochon-
drial ribosomal protein S15 (MRPS15) were tested for reference gene
Table 1
Characteristics of the primer pairs used and the efficiency of amplification.
Gene Primer sequence (5' to 3') Accession Number bp % Efficiency
PARP1 For-CATCGTCAAAGGGACCAACT NM_174751 158 100–104
Rew-AAATGCTCAATGGCATCCTC
ATP5B For-TTTGGACTCCACGTCTCGCATC NM_175796.2 108 97–102
Rew-TCCTGGAGGGATTTGTAGTCCTG
MRPS15 For-GCAGCTTATGAGCAAGGTCGT NM_001192201.1 151 99–103
Rew-GCTCATCAGCAGATAGCGCTT
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suitability based on the findings of previous studies (Bionaz and Loor,
2007; Crisà et al., 2013). Information on PCR primer sets is summarized
in Table 1. Total RNA extraction from PBMC and sorted lymphocytes
and monocytes was performed using the RNeasy Micro Kit (Qiagen)
according to the manufacturer’s instructions. RNA purity was measured
by spectral photometry (NanoPhotometer® Pearl, IMPLEN). RNA in-
tegrity was assessed on Agilent 2100 Bioanalyzer (Agilent Technolo-
gies). All of the RNA samples used in this study had RIN values ranging
between 8.8 to 9.8. Complementary DNA (cDNA) was synthesized from
1μg of total RNA using a Maxima First Strand cDNA Synthesis Kit
(ThermoFisher Scientific). PCR for each sample was carried out in tri-
plicate using an iCycler iQ System (BioRad). A six-point standard curve
was generated for each gene using a 2-fold dilution of cDNA in order to
determine amplification efficiency for each couple of primers. The PCR
was performed in a 30 μL final volume containing 50 ng of cDNA, 15 μL
of SYBR Premix Ex Taq™ (Takara) and 0.6 μL each of 10 μM forward
and reverse primers.
All of the samples were analyzed in triplicate and each plate in-
cluded the no-template and minus-reverse transcription samples as
controls. Amplification conditions for PARP1, MRPS15 and ATP5B were
as follows: denaturation step at 95 °C for 30 s; 40 cycles of 95 °C for 5 s,
60 °C for 30 s A melting curve analysis (60–90 °C) with a heating rate of
0.5 °C/sec) was carried out to check the specificity of the amplification
and to detect the presence of non-specific amplicon. The sequence of
amplified product was confirmed by direct sequencing on the Genetic
Analyzer (Applied Biosystems). The PARP1 expression was normalized
using both MRPS15 and ATP5B according to 2−ΔCt equation, con-
sidering that the threshold CT value of the 2 reference genes are com-
parable in the different population of cells (PBMC, monocytes and
lymphocytes obtained from the same animal). The results, expressed as
mean ± SD of three independent experiments carried out on five dif-
ferent cows, represent the relative expression level computed as the
difference between the PARP1 gene CT and both MRPS15 and ATP5B
CT values.
2.3. Trial 2
2.3.1. Purification of milk somatic cells
Milk samples (100mL) were collected from nine cows and a total of
36 quarter milk samples were analyzed. The International Dairy
Federation (IDF) currently recommends carrying out both SCC and
bacteriological analysis as criteria for determining udder health. Milk
somatic cells include macrophages, PMN and lymphocytes that exist
initially in blood together with epithelial cells from the mammary
gland.
The amount of somatic cells in each milk sample was measured with
a DeLaval Cell counter DCC instrument (DeLaval International AB) and
the experimental design was established to divide the quarter milk
samples into two groups: Group 1 composed of 17 samples with
SCC≤ 100,000 cells/mL and Group 2 composed of 19 samples with
SCC > 100,000 cells/mL. Immediately after collection, the milk sam-
ples were centrifuged at 800g for 15min at 8 °C and the fat layer and
supernatant were discarded. The cell pellets were washed twice with
40mL of cold PBS and aliquots of 1.0*106 cells were stored at −80 °C
for later PAR quantification.
2.3.2. Assessment of PAR concentration in milk somatic cells
The HT PARP in vivo Pharmacodynamic Assay II (Trevigen), which
measures the net concentration of PAR in cellular extracts, was used to
determine the PAR level in milk somatic cells. The assay was run ac-
cording to the manufacturer’s instructions. PAR concentration was
quantified as a chemiluminescent signal measurement (Victor X light
instrument, Perkin Elmer Inc.) and the PAR concentration was reported
as pg/mL per 1.0*106 cells. Purified PAR polymers supplied with the kit
were used to create a standard curve with trend line. The standard
curve ranged from 10-1000 pg/mL. The R2 value for the linear curve fit
was 0.993. Jurkat cell lysates were used as standards to control assay.
2.3.3. Flow cytometric analysis of milk somatic cells
Out of 36 quarter milk samples, 12 were analyzed by flow cytometry
to perform the determination of different types of immune cells in milk.
A three-colour flow-cytometric analysis was performed to identify total
leukocytes and to differentiate lymphocytes from phagocytes
[PMN+monocytes/macrophages].
In short, 100 μL of the cell suspension at 1×106cells/mL were in-
cubated on ice for 30min in the dark, with 5 μL of PE-conjugated anti-
bovine CD45 antibody (clone CC1, BioRad), 5 μL of FITC- conjugated
anti-bovine CD11b (clone CD126, Bio-Rad) and 5 μL of APC- conjugated
anti-human CD14 (clone TÜK4, Miltenyi Biotec). After incubation, the
cells were washed twice with cold PBS and resuspended in 300 μL of
PBS for the flow cytometric analysis. Stained samples were analyzed
with FC500 Flow Cytometer Analyzer (Beckman Coulter Inc.) and the
data were analyzed with Kaluza Analysis Software (Beckman Coulter
Inc.). Besides debris exclusion, PMN and monocytes/macrophages were
identified with the gating strategy as CD45+/CD11b+/CD14− cells and
CD45+/CD11b+/CD14+ cells respectively; lymphocytes were identi-
fied by size and granularity (FSC-H vs SSC-H) and as CD45+/CD11b-/
low/CD14- cells.
2.4. Statistical analysis
Differences in PAR level, lymphocytes or phagocytes percentages
between SCC classes (SCC≤ 100,000 cells/mL and SCC > 100,000
cells/mL) were evaluated with the following ANOVA model:
yij=μ + ci + eij
Where:
yij=PAR levels (pg/mL), lymphocytes or phagocytes percentage;
ci= fixed effect of the SCC classes: (i = 1, 2);
eij= random residual effect.
3. Results
3.1. Differential PARP1 expression in bovine PBMC (Trial 1)
PARP1 protein levels were detected in freshly isolated PBMC and in
lymphocytes and monocytes. Western blot analyses (Fig. 1A), con-
firmed the presence of a protein of the expected molecular weight
(116 kDa). The presence of the 89 kDa band in PBMC and lymphocytes,
protein corresponding to the PARP1 fragment derived from the Cas-
pase3-dependent apoptotic cleavage of the protein, suggest some
apoptosis activity in these cells. Densitometric analysis of the 116 kDa
band indicates that the full length protein was present at much higher
levels in lymphocytes (3.4 fold) than in monocytes (Fig. 1B).
To verify whether the low level of PARP1 protein in monocytes
resulted from low mRNA expression, we performed RT-qPCR analysis of
the freshly sorted cells. Fig. 1 (C, D) shows the relative expression of
PARP1 mRNA in lymphocytes and monocytes compared to unsorted
PBMC and normalized to MRPS15 and ATP5B. These two candidate
reference genes (Table 1) were selected through the analysis of litera-
ture survey on studies in bovine with RT-qPCR analysis (Bionaz and
Loor, 2007; Crisà et al., 2013 and some still unpublished results). They
can be considered good as reference genes for the comparison of PARP1
expression in different cell types since their expression is stable with
low coefficient of variation CV in different bovine samples tested in
different experiments (data not shown) and there are no substantial
differences in gene expression between PBMC, lymphocytes and
monocytes, both for MRPS15 and ATP5B. Results highlighted that
PARP1 expression was much higher in lymphocytes than in monocytes
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(3 fold higher normalizing with ATP5B - 7.5- fold normalizing with
MRPS15), confirming the results of the protein analyses shown in
Fig. 1B.
3.2. PARP1 and PAR levels are increased in bovine PBMC of animals with
bacterial infection
In order to analyze PARP activity, we evaluated the presence of PAR
which is an indirect measurement of PARP activity. As preliminary
control, Doxo was added to HCT116 cell line and the resulting increase
in PAR was measured by immunoblotting analysis. HCT116 cell line
was used as control because the concentration of Doxo and incubation
time was previously standardized to produce a non-apoptotic damage
with a time-dependent PAR formation (Bacalini et al., 2011). In the
presence of Doxo a clear increase in PAR level was detectable as early as
30min after the treatment and PAR increased in a time-dependent
manner until 2 h (Fig. 2A). Treatment with ABT-888, a specific inhibitor
of PARP activity, induced a clear inhibition of PAR synthesis in Doxo-
treated cells, confirming the specificity of PAR detection.
Immunoblotting analysis was performed to detect PARP1 and PAR
levels in PBMC of infected versus non infected dairy cows (Fig. 2B).
Purified PBMC of cow naturally infected by S. aureus exhibited higher
levels of 116 kDa full-length PARP1 protein compared to the healthy
control. The presence of 89 kDa PARP1 fragment in the sample from the
infected cow suggested apoptosis activity. In addition, the concomitant
formation of PAR polymers suggested PARP1 activity.
Fig. 1. Differential PARP1 expression in PBMC.
A) Representative Western blot of PARP1 detected with the monoclonal antibody C2-10 (which detects the full length 116 kDa PARP1, and the apoptosis-related
89 kDa fragment) in freshly isolated PBMC, in lymphocytes and monocytes isolated from PBMC by magnetic beads cell sorting using an anti-CD14 antibody. B)
Densitometric analysis of the PARP1 higher band (116 kDa). PARP1 protein levels were normalized to β-actin levels and indicated as a ratio with respect to PBMC
cells, setting protein levels on PBMC to 1. C) Real-time PCR measurements of PARP1 mRNA levels in PBMC andisolated lymphocytes and monocytes by magnetic
beads cell sorting using an anti-CD14 antibody. Box plots showing PARP1 mRNA levels normalized to MRPS15 and to ATP5B. The results are expressed as
mean ± SD of three independent experiments performed in five cows. Significant differences between PBMC, lymphocytes and monocytes are indicated (* = p-value
≤0.05; **= p-value<0.01 by Student's t-test).
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3.3. High PAR levels in milk quarter samples with high somatic cell count
(Trail 2)
To verify the presence of PAR in milk cells, samples from 17 quar-
ters from Group 1 (SCC < 100,000 cells/mL) and 19 quarters from
Group 2 (SCC > 100,000 cells/mL) were collected. The average of SCC
in Group 1 (46,882 ± 23,545 cells/mL) and in Group 2
(319,707 ± 294,100 cells/mL) differed significantly (p-value =
0.002).
We measured intracellular PAR amounts with the HT PARP in vivo
Pharmacodynamics assay.
The results indicate that PAR level is significantly higher in Group 2
(308.74 ± 209.92 pg/mL/1.0×106 cells) as compared to Group 1
(131.85 ± 97.05 pg/mL/1.0×106 cells) with a p-value=0.003
(Fig. 3 and Table 2).
Fig. 2. PARP1 and PAR levels in PBMC from
cows naturally affected by bacterial infec-
tion.
A) Time course of PAR formation in HCT116
cells after treatment with 1 μM Doxorubicin
(Doxo) in the presence or absence of ABT-888
(30min pre-treatment). Western blotting was
performed on total cell extracts using anti-
bodies against PAR and β-actin. B)
Representative Western blot of PARP1 protein
and PAR formation in PBMC purified from
blood of infected and non-infected cows. Data
shown are representative of two independent
experiments.
Fig. 3. PAR levels in cells isolated from quarter milk samples.
Box plot showing PAR level (pg/ml/1 * 106 cells) detected in milk samples coming from two different categories of bovine udder quarters: quarters with
SCC≤ 100,000 cells/mL and quarters with SCC > 100,000 cells/mL.
Table 2
PAR level in purified milk cells coming from udder quarters with differential
SCC.
SCC≤ 100,000
cells/mL
SCC > 100,000
cells/mL
P-value
(n= 17) (n= 19)
Mean SE Mean SE
PAR
(pg/mL/
106
cells)
131,85 40,41 308,74 38,23 0.003
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Besides the determination of SCC, we analyzed the cellular com-
position of the leukocyte population in milk from udder quarters of
cows in healthy (SCC≤ 100,000 cells/mL) and potential inflammatory
conditions (SCC > 100,000 cells/mL).
Flow cytometry analysis (Fig. 4A–C) showed that quarters with
SCC > 100,000 cell/mL mainly consisted of phagocytes
(64.30 ± 27.50) while lymphocytes were lower (31.8 ± 27.01). On
the other hand, in milk samples with SCC≤ 100,000 cell/mL lym-
phocytes were the predominant cell type (63.65 ± 23.41) compared to
the phagocytes population (31.04 ± 22.59). The difference between
the percentage of lymphocytes and phagocytes was significant both in
healthy (p-value = 0.05) and infected quarters (p-value = 0.05)
(Fig. 4D, E and Table 3).
4. Discussion
This study provides for the first time insights on PARP1 expression
and its activity in dairy cattle. Our results show that within PBMC
population PARP1 is highly expressed in lymphocytes as compared to
monocytes.
This result is in accordance with the findings that human monocytes
show low expression of four DNA repair proteins, including PARP1, as
reported by Bauer et al., (2012). Despite the low expression of PARP1 in
monocytes, Aldinucci et al., (2007) reported that PARP1 activity plays a
key role during human dendritic cell maturation and Hauschildt et al.,
(1997) showed that poly(ADP-ribosyl)ation is a crucial protein mod-
ification involved in intracellular processes leading to activation of
monocytes/macrophages.
Over the last decade, a number of studies have verified the role of
PARP activation in a wide range of pathophysiological conditions,
Fig. 4. Identification of main leukocyte populations in milk samples by flow cytometric analysis.
A) The anti-bovine CD45 antibody was used for the detection of milk leukocytes and a gate around CD45+cells was drawn. Fourteen thousand CD45high cells from
each sample were acquired for the analysis. B) Dot plot showing the back gate of CD45+ cells in a forward scatter (FSC) vs side scatter (SSC); C) Dot plot showing
percentages of lymphocytes, monocytes/macrophages and PMN leukocytes. Lymphocytes were identified by size and granularity (FSC-H vs SSC-H) and as CD45+/
CD11blow/−/CD14- cells. Phagocytes were calculate as the sum of PMN leukocytes and monocytes/macrophages originated from the analysis. D) and E) Boxplots
showing the percentages of lymphocytes and phagocytes detected in two SCC categories of quarter milk samples, SCC≤ 100,000 cells/mL and SCC > 100,000 cells/
mL. Results shown in Table 3 are reported as mean ± SD.
Table 3
Percentage of leukocyte populations in milk samples coming from udder quarters with differential SCC.
SCC≤ 100,000 cells/mL SCC > 100,000 cells/mL P-value
(n= 6) (n= 6)
Mean SD Mean SD
Lymphocytes (%) 63.65 23.41 31.8 27.01 0.05
Phagocytes (%) 31.07 22.59 64.30 27.50 0.05
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including inflammation. Several studies on human inflammatory dis-
eases have reported the involvement of poly(ADP-ribosyl)ation and
PARP1, both locally and in circulating leukocytes (Murthy et al., 2004;
Tempera et al., 2005; Grecchi et al., 2012). Furthermore, in vivo and in
vitro studies demonstrated that PARP1 activation is involved in the
cellular response to oxidative DNA damage in equine peripheral blood
mononuclear cells, and suggest PARP inhibitors as potential therapeutic
agents for intestinal ischemia-reperfusion injury (Douglas et al., 2015).
Taking into consideration the involvement of PARP1 in in-
flammatory conditions, we decided to investigate whether poly(ADP-
ribosyl)ation increased during udder inflammation in dairy cattle both
on PBMC and cells isolated from milk of potentially infected cows.
Cells isolated from quarter milk were divided based on the already
described 100,000 cells/mL SCC threshold. The SCC is a well-estab-
lished, robust and quantitative measurement in the diagnosis of mas-
titis, as SCC increases evidently during mastitis, and the composition of
the leukocytes population changes significantly (Schwarz et al., 2011).
Interestingly, we can observe PAR accumulation in PBMC from
diseased cows udder and significantly higher levels of PAR in quarters
with higher SCC relative to quarters with lower SCC, supporting the
conclusion that PARP1 activity increases significantly during mastitis
(p-value<0.03).
Characterization of milk cell population showed that quarters with
high SCC exhibit a significant increase in phagocytes (combined pro-
portion of PMN and monocytes/macrophages), which are cells involved
in the inflammatory response. Phagocytes are the first line of defence at
tissue level as they migrate from the blood to the peripheral tissues in
response to infectious and inflammatory stimuli.
Ours findings show therefore that increased SCC is associated with
PARP1 activation during bovine mastitis. Considering that monocytes
are important players in the inflammatory response, the significant high
PAR level detected in somatic cells purified from quarters with
SCC > 100,000 cells/mL could be ascribed also to PARP1 activation in
the increased proportion of monocytes/macrophages in spite of their
lower expression of the enzyme respect to lymphocytes. Thus, the high
PAR level, resulting from involvement of both lymphocytes and
monocytes in PARP activity, is associated with a change in cell com-
position in the high SCC group. The importance of the role played by
PAR synthesis in inflammation is supported by a recent paper showing
the presence of extracellular PAR derived from necrosis of macrophages
with hyperactivated PARP1. Authors have provided evidence of a novel
function for PAR as a signal for macrophages to engage the immune
system at the site of infection (Krukenberg et al., 2015).
In summary, our results show that (i) bovine PBMC express PARP1;
(ii) lymphocytes exhibit higher expression of PARP1 than monocytes;
(iii) PARP1 and PAR levels are higher in circulating PBMC of infected
cows and (iv) PAR levels are higher in cells isolated from milk with
higher somatic cell count (SCC > 100,000cells/mL).
Our data suggest an association between PARP1 activation and
mastitis, although further investigation will be required to define the
role of poly(ADP-ribosyl)ation in udder inflammation of dairy cattle. It
would be of particular interest to verify if PAR level in milk somatic
cells could have predictive value for diagnosing mastitis.
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